Navigation Links
Increase in Genomic Replikin Counts Predicted Recent Avian Flu (H5N1) Outbreak in Cambodia
Date:7/30/2012

LONDON, July 30, 2012 /PRNewswire/ -- A marked increase in the H5N1 pB1 Lethality Gene Replikin Count (number of Replikins per 100 amino acids) in Cambodia in 2009 (Figure 1 below) provided a warning for the outbreaks of the Avian Flu (H5N1) with human deaths in that country. Eight deaths were reported in 2011 and three thus far in 2012.

This was one of seven consecutive correct predictions by genomic Replikins of coming viral outbreaks tied to specific geographical locations (Refs. 1, 3-5), thus raising the question: can a flu pandemic be prevented? The United Nations Food & Agricultural Organization (FAO) noted (Ref. 3) that increases in Replikin Count like those in the Figures, have been followed by an outbreak 1-2 years later (Refs. 1, 5).

(Photo: http://photos.prnewswire.com/prnh/20120730/NY48806 )

In contrast to the increase in the Lethality Gene, the Replikins Infectivity Gene was not increased in 2009 beyond the levels in the Indonesia H5N1 outbreaks of 2006, giving hope that the present outbreak might remain limited. However, as seen in Figure 1b, the evolution of H5N1 (Ref. 4) has continued. The H5N1 Infectivity Gene Replikin Count has increased in Cambodia to the highest recorded percent of sequences with Replikin Counts greater than 4.0 (p<0.001).

Highs of H5N1 Infectivity and Lethality Gene Replikin Counts in Cambodia are duplicating the time-course of H1N1 Replikins 2006-2008 in Mexico (Ref. 5), which preceded the 2009 H1N1 Pandemic and permitted its prediction from Replikin Count alone (1). Further, just as sporadic human deaths due to H1N1 occured in the pre-H1N1 pandemic years in Mexico, sporadic H5N1 deaths are occurring in Cambodia due to proven H5N1.

Early Warning & Synthetic Vaccines

Because of this early warning system specific to the strain, the genomic Replikin structures, and the geographic site, pandemic prevention at a limited geographic site can be attempted now for the first time with synthetic vaccines, and are applicable to the current conserved genomic H5N1 Replikin sequences identified in Cambodia.

Completely synthetic solid phase vaccines, composed of peptides only (not DNA, avoiding the risks of vaccine DNA being permanently incorporated into human genomes), synthesized in seven days, and shipped in freeze-dried form, have been found effective against H5N1 in chickens and against Taura Syndrome Virus in shrimp (Refs.6,7).           

                                                                                                                                                                                     

References:                                                                          

1. Bogoch S, Bogoch ES.   Replikins Pandemic Prevention: Increase of Strain-Specific Influenza Genomic Replikin Counts, Having Predicted Outbreaks and their Location Seven Times Consecutively, Up to Two Years in Advance, Provides Time for Prevention of Pandemics.  Nature Precedings doi:10.1038/npre.2012.6952.1                                                                       

2. WHO and Ministry of Health, Cambodia Press Releases. August 23, 2011 and June 5, 2012

3. UN Food and Agriculture Organization (FAO) discussion of Replikins. DVM Newsmagazine Rome Sept. 8, 2011

4. Report #49. Replikins Press<replikins.com>.Discovered Evolution of Genomic Sequences -- from Ocean Archaea to Brain Cancer -- Leads to New Synthetic Replikin Vaccines for Infectious Diseases and Cancer, June 19, 2012

5. Bogoch S, Bogoch ES. Prediction of specific virus outbreaks made from the increased concentration of a new class of virus genomic peptides, replikins. Nature Precedings doi:10.1038/npre.2011.6279.1

6. Jackwood et al . Efficacy of a Replikin Peptide Vaccine against Low Pathogenicity Avian Influenza H5 VirusAvian Diseases 53(4):613-617, 2009.

7. Report # 17. Replikins Press<replikins.com>.Replikins Oral Vaccine Synthesized in 7 days protects 91% of Shrimp Against Lethal Virus . March 11, 2008.


'/>"/>
SOURCE Replikins Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. iDiverse Discovers Yeast Gene that Increases Fuel Ethanol Production Yield
2. Solar nanowire array may increase percentage of suns frequencies available for energy conversion
3. Trade Show Display Company GLM Displays Increase Sales with New E-commerce Website
4. ResearchMoz: Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar- Market Research Report
5. U.S. Senate Urged to Increase Federal Funding for Research into Hereditary Angioedema, a Rare and Serious Genetic Disorder
6. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
7. Childhood Obesity Linked to Increased Risk of Hepatocellular Carcinoma in Adulthood
8. European Multiple Sclerosis Market in Dire Need of Increased Disease Awareness and Treatment Options, Cautions Frost & Sullivan
9. Increased fertility rate for IVF patients achieved by new equipment design
10. HPV Testing for Cervical Cancer Risk Patients set to Increase
11. GeNO LLC Makes Significant Additions to Management Team to Increase Capability and Talent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Savannah River Remediation LLC group ... NewTechBio,s NT-MAX Lake & Pond Sludge and ... in conjunction with Hexa Armor/ Rhombo cover manufactured ... Pollutant Discharge Elimination System requirements. The ... history of elevated pH levels, above 8.5, especially ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. presented today ... clinical trial for its lead drug candidate, AC0010, at the World Conference on ... to determine the safety, antitumor activity, and recommended phase II dosage of AC0010 ...
(Date:12/7/2016)... 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical ... immunotherapeutic products for the treatment of cancer, today ... Manufacturing Development Program with Cytovance Biologics ( ... oregovomab antibody product. Supported by recent positive interim ... in ovarian cancer patients, OncoQuest has engaged Cytovance ...
(Date:12/7/2016)... The report "Acrylic Processing Aid Market by Polymer Type (PVC), Fabrication Process (Extrusion, Injection ... to 2026", published by MarketsandMarkets, the global market size was USD 645.4 Million ... an of CAGR of 6.2% between 2016 and 2026. ... ... , , ...
Breaking Biology Technology:
(Date:12/2/2016)... PUNE, India , December 1, 2016 /PRNewswire/ ... Market by Authentication type (Fingerprint, Voice), Future Technology (Iris ... Vehicle), and Region - Global Forecast to 2021", ... be USD 442.7 Million in 2016, and is ... 2021, at a CAGR of 14.06%. ...
(Date:11/30/2016)... 2016  higi SH llc (higi) announced today ... national brands, industry thought-leaders and celebrity influencers looking ... for taking steps to live healthier, more active ... higi has built the largest self-screening health station ... people who have conducted over 185 million biometric ...
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's ... Systems) ... largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of an ...
Breaking Biology News(10 mins):